Brief: Bolt Biotherapeutics Reports Q4 Results

Bolt Biotherapeutics

29/03/2023 21:49

March 29 (Reuters) - Bolt Biotherapeutics Inc  BOLT.O :
    * BOLT BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * CASH BALANCE OF $192.8 MILLION ANTICIPATED TO FUND KEY
MILESTONES THROUGH 2025
    * QTRLY LOSS PER SHARE $0.53
    * Q4 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4dZWyL 
Further company coverage:  BOLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))